Literature DB >> 32016671

Dynamic Changes in Pre- and Postoperative Levels of Inflammatory Markers and Their Effects on the Prognosis of Patients with Gastric Cancer.

Jian-Xian Lin1,2,3,4, Zu-Kai Wang1,2, Ying-Qi Huang1,2, Jian-Wei Xie1,2,3,4, Jia-Bin Wang1,2,3,4, Jun Lu1,2, Qi-Yue Chen1,2, Mi Lin1,2, Ru-Hong Tu1,2, Ze-Ning Huang1,2, Ju-Li Lin1,2, Chao-Hui Zheng5,6,7,8, Chang-Ming Huang9,10,11,12, Ping Li13,14,15,16.   

Abstract

BACKGROUND: Whether the change of the pre- and postoperative systemic inflammatory response (SIR) levels will affect the prognosis of gastric cancer (GC) is unclear. We aimed to investigate the dynamic changes in the pre- and postoperative SIR and their prognostic value for GC.
METHODS: The clinicopathological data from 2257 patients who underwent radical gastrectomy between January 2009 and December 2014 at Fujian Medical University Union Hospital (FMUUH) were analyzed. Perioperative SIR changes were reported as changes in the lymphocyte-monocyte ratio (LMR), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII).
RESULTS: The SIR levels showed different trends from postoperative months 1 to 12. Multivariate analysis showed that preoperative (pre)-LMR was an independent predictor for the prognosis (P = 0.024). The postoperative 12-month (post-12-month) LMR predicted the 5-year overall survival (OS) rate with the highest accuracy (areas under the curve [AUC] 0.717). Patients were divided into four groups according to the optimal cutoff of the preoperative and post-12-month LMR: high pre-LMR to high postoperative (post)-LMR group, high pre-LMR to low post-LMR group, low pre-LMR to high post-LMR group, and low pre-LMR to low post-LMR group. The survival analysis showed 5-year OS rate was significantly higher in patients with high post-12-month LMR than in patients with low post-12-month LMR, regardless of pre-LMR levels (81.6% vs. 44.2%, P < 0.001). The prognostic accuracy was significantly improved by incorporating the post-12-month LMR in the tumor-node-metastasis (TNM) staging system (P = 0.003).
CONCLUSIONS: The remeasurement of LMR at post-12-month is helpful in predicting the long-term survival of GC.

Entities:  

Keywords:  Gastric Cancer; Prognosis; Systemic inflammatory response

Mesh:

Year:  2020        PMID: 32016671      PMCID: PMC7904717          DOI: 10.1007/s11605-020-04523-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  29 in total

1.  Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer.

Authors:  R Carruthers; L M Tho; J Brown; S Kakumanu; E McCartney; A C McDonald
Journal:  Colorectal Dis       Date:  2012-10       Impact factor: 3.788

2.  Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer.

Authors:  Jian-Xian Lin; Jun-Peng Lin; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ruhong Tu; Chao-Hui Zheng; Chang-Ming Huang; Ping Li
Journal:  Gastric Cancer       Date:  2018-07-07       Impact factor: 7.370

3.  X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Authors:  Robert L Camp; Marisa Dolled-Filhart; David L Rimm
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

Review 4.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

Authors:  Aaron J Schetter; Niels H H Heegaard; Curtis C Harris
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

5.  C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer.

Authors:  Nevin Ilhan; Necip Ilhan; Yavuz Ilhan; Handan Akbulut; Mehmet Kucuksu
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

Review 6.  Cancer-related inflammation.

Authors:  Alberto Mantovani; Paola Allavena; Antonio Sica; Frances Balkwill
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

7.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

8.  Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer.

Authors:  Xuechao Liu; Xiaowei Sun; Jianjun Liu; Pengfei Kong; Shangxiang Chen; Youqing Zhan; Dazhi Xu
Journal:  Transl Oncol       Date:  2015-08       Impact factor: 4.243

9.  The Prognostic Role of the Platelet-Lymphocytes Ratio in Gastric Cancer: A Meta-Analysis.

Authors:  Zhengshui Xu; Wei Xu; Hua Cheng; Wei Shen; Jiaqi Ying; Fei Cheng; Wenji Xu
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

10.  Preoperative lymphocyte-to-monocyte ratio (LMR) could independently predict overall survival of resectable gastric cancer patients.

Authors:  Yu-Chen Pan; Zhi-Fang Jia; Dong-Hui Cao; Yan-Hua Wu; Jing Jiang; Si-Min Wen; Dan Zhao; Song-Ling Zhang; Xue-Yuan Cao
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

View more
  12 in total

1.  Perioperative lymphocyte-to-monocyte ratio changes plus CA199 in predicting the prognosis of patients with gastric cancer.

Authors:  Wenjing Zhao; Guoxin Mao; Yueyue Zhu
Journal:  J Gastrointest Oncol       Date:  2022-06

2.  Expression and prognostic value of ratios of platelet lymphocyte, neutrophil lymphocyte and lymphocyte monocyte in breast cancer patients.

Authors:  Deba Song; Xiaoxu Li; Xiaojian Zhang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

3.  The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment.

Authors:  Bong Kyung Bae; Hee Chul Park; Gyu Sang Yoo; Moon Seok Choi; Joo Hyun Oh; Jeong Il Yu
Journal:  Cancers (Basel)       Date:  2022-04-21       Impact factor: 6.575

4.  Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study.

Authors:  Xiaoyang Li; Sifeng Li; Zhenqi Zhang; Dandan Huang
Journal:  PeerJ       Date:  2022-05-19       Impact factor: 3.061

5.  Prognostic value of systemic immune-inflammatory index in survival outcome in gastric cancer: a meta-analysis.

Authors:  Shifeng Fu; Jin Yan; Yuyong Tan; Deliang Liu
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 6.  Potential Therapeutic Action of Autophagy in Gastric Cancer Managements: Novel Treatment Strategies and Pharmacological Interventions.

Authors:  Md Ataur Rahman; Kazi Rejvee Ahmed; Md Hasanur Rahman; Moon Nyeo Park; Bonglee Kim
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

7.  Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population.

Authors:  Agnieszka Pikuła; Magdalena Skórzewska; Zuzanna Pelc; Radosław Mlak; Katarzyna Gęca; Katarzyna Sędłak; Bogumiła Ciseł; Magdalena Kwietniewska; Karol Rawicz-Pruszyński; Wojciech P Polkowski
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.639

8.  Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.

Authors:  Xunlei Zhang; Wenjing Zhao; Yang Yu; Xue Qi; Li Song; Chenfei Zhang; Guoxing Li; Lei Yang
Journal:  World J Surg Oncol       Date:  2020-07-30       Impact factor: 2.754

9.  The preoperative and the postoperative neutrophil-to-lymphocyte ratios both predict prognosis in gastric cancer patients.

Authors:  Eun Young Kim; Kyo Young Song
Journal:  World J Surg Oncol       Date:  2020-11-10       Impact factor: 2.754

Review 10.  Systematic Review of Prognostic Role of Blood Cell Ratios in Patients with Gastric Cancer Undergoing Surgery.

Authors:  Sabine Schiefer; Naita Maren Wirsik; Eva Kalkum; Svenja Elisabeth Seide; Henrik Nienhüser; Beat Müller; Adrian Billeter; Markus W Büchler; Thomas Schmidt; Pascal Probst
Journal:  Diagnostics (Basel)       Date:  2022-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.